第1天 | 第2天 |
糖尿病的创药
2型糖尿病在全世界广泛可见中，在糖尿病创药领域正进行热烈的研究，为了不落人后，我们也安排许多应讨论的主题。针对2型糖尿病的创药和药剂开发领域的风险与进展，可与同业者进行讨论。透过在讲台的发表和由专家主持的专题讨论会、讨论会等，可谈论下一代的糖尿病治疗药等级、口服糖尿病治疗候选药临床的发展、胰岛素感受性或血糖值下降之标的有效性、以及前临床开发之新标的等话题。
11月3日 星期四
1:30 pm Chairperson’s Remarks
1:40 FEATURED PRESENTATION:
Inhibiting Glucose Transporters via SGLT inhibitors – the Next New Diabetes Drug Family?
Michael Mark, Ph.D., Vice President, CardioMetabolic Diseases Research, Boehringer Ingelheim
This presentation will provide an update on diabetes drug candidates in late stage development, with a focus on compounds targeting sodium glucose transporters. Current challenges faced in the field of diabetes drug development will also be covered.
|
2:25 FEATURED PRESENTATION:
Diabetes Drug Targets from Gastric Bypass Surgery
 Lee M. Kaplan, M.D., Ph.D., Professor, Harvard Medical School
|
3:10 Networking Refreshment Break in the Exhibit Hall with Poster Viewing
3:45 A Physician’s Perspective on the Future of Diabetes Treatments
Rohit N. Kulkarni, M.D., Ph.D., Associate Professor, Medicine, Harvard Medical School; Investigator, Joslin Diabetes Center
This presentation will discuss the scope of the global diabetes problem and which types of diabetes treatments are most needed from a diabetes physician’s and his patients’ perspective to help provide a relevant context to scientists developing new diabetes treatments.
4:15 Sponsored Presentations (Opportunities Available)
4:45 Diabetes Market Landscape
Kelly Close, MBA, President, Close Concerns
5:15 Panel Discussion: Diabetes Drug Development
Moderator: Rebecca Taub, M.D., Senior Vice President, Research and Development, VIA Pharmaceuticals
Developing diabetes drugs in Asia – how is it different? Is that the future? What will clinical trials look like five years from now? What is the ideal diabetes treatment regimen?
|
5:45 End of Day
第1天| 第2天 |
